ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 747652 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 747652; 2) Community: the network communities that were significantly associated with the response to NSC 747652; 3) Molecule: the relationships between components within communities and NSC 747652; 4) MDR: the compounds that were significantly associated with the NSC 747652.

NSC Compound Enrichment Correlation
NSC 762149 N-(4-{2-[(1R,6R,11aS,13S,14aR)-1,13-dihydroxy-4-oxo-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-6-yl]ethyl}phenyl)acetamide 0.0222343516878698 -0.29036424
NSC 83715 Null 0.0222343516878698 0.34153014
NSC 92915 ANTINEOPLASTIC-92915 0.0222343516878698 0.41293795
NSC 94037 Mikanolide 0.0222343516878698 0.44869471
NSC 96541 Benzo[f]quinoline-3-carbonitrile, 4-benzoyl-3,4-dihydro- (8CI9CI) 0.0222343516878698 0.260689
NSC 123979 Thevetin 0.0244632509325736 0.28781976
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.0244632509325736 0.34248213
NSC 136468 Null 0.0244632509325736 0.47787946
NSC 169774 Bromocriptine methanesulfonate 0.0244632509325736 0.45778198
NSC 254677 Phomazarin 0.0244632509325736 -0.090791728
Total:86  Current:46    [First] [Prev] [Next] [Last]